LobbyingKardiogenics lobbying by quarter
Kardiogenics's latest lobbying report covers Q3 2026, at under $5,000. Its first report covers Q4 2023; the issues it reports most are Defense and Health Issues.
Kardiogenics
- Latest quarter
- $0
- Q3 2026 · 1 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2023
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 1 |
By issue
- Defense$0 · 11 reports
- Health issues$0 · 11 reports
- Medical research and clinical labs$0 · 11 reports
- Budget and appropriations$0 · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES11 reports
- SENATE11 reports
- Defense, Dept of (DOD)9 reports
- Health & Human Services, Dept of (HHS)6 reports
- Food & Drug Administration (FDA)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tenagrity Solutions | $0 | 12 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNY CAROLINE DEBERRY | Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/24for Q3 | Tenagrity Solutions | Under $5,000 |
| 07/20for Q2 | Tenagrity Solutions | Under $5,000 |
| 04/20for Q1 | Tenagrity Solutions | Under $5,000 |
| 01/20for Q4 2025 | Tenagrity Solutions | Under $5,000 |
| 25/10/20for Q3 2025 | Tenagrity Solutions | Under $5,000 |
| 25/07/21for Q2 2025 | Tenagrity Solutions | Under $5,000 |
| 25/04/21for Q1 2025 | Tenagrity Solutions | Under $5,000 |
| 25/01/14for Q4 2024 | Tenagrity Solutions | Under $5,000 |
| 24/10/17for Q3 2024 | Tenagrity Solutions | Under $5,000 |
| 24/07/19for Q2 2024 | Tenagrity Solutions | Under $5,000 |
| 24/04/15for Q1 2024 | Tenagrity Solutions | Under $5,000 |
| 24/01/18for Q4 2023 | Tenagrity Solutions | Under $5,000 |
| 23/12/14for Q4 2023 | Tenagrity Solutions | Under $5,000 |